Genecast Minimal Residual Disease Test Plans Bolstered by New Lung Cancer Data
360Dx,
NEW YORK – Chinese cancer sequencing firm Genecast Biotechnology said this week that it plans to seek regulatory approval for…
NEW YORK – Chinese cancer sequencing firm Genecast Biotechnology said this week that it plans to seek regulatory approval for…
NEW YORK – Chinese cancer sequencing firm Genecast Biotechnology said this week that it plans to seek regulatory approval for…